Disclosed are chemical entities that inhibit Uba6, each of which is a compound of Formula /: Formula (I) or a pharmaceutically acceptable salt thereof, wherein R*1 is -H or -CH3; and Y is Formula (II) or Formula (III), wherein R2 is -H, -CH3 or C1-4 alkyloxycarbonyl; and RS7.1, RS7.2 and RS8.1 are defined herein; pharmaceutical compositions comprising the chemical entities; and methods of using the chemical entities. These chemical entities are useful for treating disorders, particularly cell proliferation disorders, including cancers.
本文披露了抑制Uba6的
化学实体,每个实体都是化合物Formula (I)或其药学上可接受的盐,其中R*1为-H或-
CH3;Y为Formula (II)或Formula (III),其中R2为-H,- 或C1-4烷氧羰基;RS7.1,RS7.2和RS8.1在此有定义;包括这些
化学实体的药物组合物;以及使用这些
化学实体的方法。这些
化学实体对治疗疾病特别是细胞增殖紊乱,包括癌症,具有用处。